BRIEF-Ipsen SA signs exclusive licensing agreement with Otonomy Inc.

* Has entered into an exclusive licensing agreement enabling Otonomy Inc. to utilize Ipsen`s gacyclidine data in development and registration of OTO-311
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.